A new psychiatric practice in Warwick, Rhode Island, is preparing to launch with an innovative approach to mental health treatment. Comprehensive psychiatric services at Arzilence Psychiatry combine traditional clinical care with modern psychiatry, digital wellness tools, and in-depth patient education, creating an integrated system for treating complex mental health conditions. The overall vision is of “an integrated system designed to help people move beyond symptom relief toward durable change”.
Bridging Clinical Care and Technology
Founded by Dr. Paul Bowary, a Brown University–trained psychiatrist and neuroscientist, the practice focuses on mood disorders, anxiety, OCD, and adult ADHD, among other conditions. Arzilence’s three-part model—clinical treatment, digital wellness support, and psychoeducation—aims to translate insight from the clinic into everyday practice.
At the center of its digital innovation is ArziFlow, a neuroscience-inspired wellness platform designed specifically for adults with ADHD and executive function challenges. Using visual metaphors and AI-guided prompts, ArziFlow helps users plan, reflect, and calibrate daily routines—while deepening self-understanding and turning awareness of personal patterns into lasting behavioral change.
Education as Medicine
The practice’s educational arm, Arzilence Academy, reflects a simple belief: growth happens through understanding. The Academy offers structured, accessible learning about conditions, treatment options, and the science behind care—so patients and families can participate more confidently and make informed decisions.
Scientific Foundation
While embracing innovation, the practice maintains strong ties to established medical science. An advisory board comprising experts in psychiatry, neurology, psychotherapy, nursing, and neuropsychology ensures that all treatments and tools are grounded in evidence.
The practice will offer advanced treatment options, including pharmacogenomic testing for medication management and FDA-cleared neuromodulation therapies for treatment-resistant conditions. Precision psychiatric treatment is always contextualized within each patient’s unique circumstances and needs.
Looking Ahead
Arzilence Psychiatry is currently in its launch phase, with ArziFlow scheduled to enter private beta testing in October 2025. The practice aims to demonstrate how psychiatric care can evolve beyond traditional models while maintaining scientific rigor and human connection.
By integrating clinical expertise, technology, and education, Arzilence is working to transform psychiatric treatment from a focus on symptom management to building lasting resilience. The practice’s approach reflects a growing understanding that effective mental health care requires more than medication alone—it demands a comprehensive system that supports patients in their daily lives.
